Viscosupplementation therapy for osteoarthritis

Sports Medicine and Arthroscopy Review

Volumn 14, Issue 3, 2006, Pages 155-162

  Brockmeier, Stephen F ^a   Shaffer, Benjamin S ^b  

^a GEORGETOWN UNIVERSITY HOSPITAL   (United States)

^b DC Sports Medicine Institute   (United States)

Author keywords

Euflexxa; Hyalgan; Hyaluronate; Hyaluronic acid; Hylan; Hylan G F 20; Orthovisc; Osteoarthritis; Sodium hyaluronate; Supartz; Synvisc; Viscosupplementation

Indexed keywords

CHONDROITIN SULFATE; DISEASE MODIFYING ANTIRHEUMATIC DRUG; EUFLEXXA; GLUCOSAMINE; HYALURONIC ACID; HYARTIL VET; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO;

CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; EXPERIENCE; EXPERIMENTAL THERAPY; HUMAN; META ANALYSIS; OSTEOARTHRITIS; OUTCOMES RESEARCH; PRIORITY JOURNAL; REVIEW; SYSTEMATIC REVIEW; TREATMENT INDICATION; TREATMENT OUTCOME; VISCOSUPPLEMENTATION THERAPY;

ADJUVANTS, IMMUNOLOGIC; HUMANS; HYALURONIC ACID; INJECTIONS, INTRA-ARTICULAR; OSTEOARTHRITIS; TREATMENT OUTCOME;

EID: 33747374125     PISSN: 10628592     EISSN: 15381951     Source Type: Journal    
DOI: 10.1097/00132585-200609000-00007     Document Type: Review

References (52)

1. Watterson JR, Esdaile JM. Viscosupplementation: therapeutic mechanisms and clinical potential in osteoarthritis of the knee. J Am Acad Orthop Surg. 2000;8:277-284.
2. Balazs EA, Denlinger JL. Viscosupplementation: a new concept in the treatment of osteoarthritis. J Rheum. 1993;20:3-9.
3. Simon LS. Viscosupplementation therapy with intra-articular hyaluronic acid: fact or fantasy? Rheum Dis Clin North Am. 1999;25:345-358.
4. Ghosh P. The role of hyaluronic acid (hyaluronan) in health and disease: interactions with cells, cartilage, and components of synovial fluid. Clin Exper Rheum. 1994;12:75-82.
5. Goldberg VM, Buckwalter JA. Hyaluronans in the treatment of osteoarthritis of the knee: evidence for disease-modifying activity. Osteoarthritis Cartilage. 2005;13:216-224.
6. Marshall KW. Viscosupplementation for osteoarthritis: current status, unresolved issues, and future directions. J Rheum. 1998;25:2056-2058.
7. Migliore A, Tormenta S, Martin LSM, et al. Open pilot study of ultrasound-guided intra-articular injection of hylan G-F 20 in the treatment of symptomatic hip osteoarthritis. Clin Rheumatol. 2005;24:285-289.
8. Tikiz C, Unlu Z, Sener A, et al. Comparison of the efficacy of lower and higher molecular weight viscosupplementation in the treatment of hip osteoarthritis. Clin Rheumatol. 2005;24:244-250.
9. Conrozier T, Bertin P, Mathieu P, et al. Intra-articular injections of hylan G-F 20 in patients with symptomatic hip osteoarthritis: an open-label, multicentre, pilot study. Clin Exp Rheum. 2003;21:605-610.
10. Marshall KW. Intra-articular hyaluronan therapy. Foot Ankle Clin N Am. 2003;8:221-232.
11. Vad VB, Bhat AL, Sculco TP, et al. Management of knee osteoarthritis: knee lavage combined with hylan versus hylan alone. Arch Phys Med Rehabil. 2003;84:634-637.
12. Waddell DD, Cefalu CA, Bricker DC. A second course of hylan G-F 20 for the treatment of osteoarthritic knee pain: 12-month patient follow-up. J Knee Surg. 2005;18:7-15.
13. Raynauld JP, Goldsmith CH, Bellamy N, et al. Effectiveness and safety of repeat courses of hylan G-F 20 in patients with knee osteoarthritis. Osteoarthritis Cartilage. 2005;13:111-119.
14. Hammesfahr JF, Knopf AB, Stitik T. Safety of intra-articular hyaluronates for pain associated with osteoarthritis of the knee. Am J Orthop. 2003;32:277-283.
15. Lussier A, Cividino AA, McFarlane CA, et al. Viscosupplementation with hylan for the treatment of osteoarthritis: findings from a clinical practice in Canada. J Rheum. 1996;23:1579-1585.
16. Kemper F, Gebhardt U, Meng T, et al. Tolerability and short-term effectiveness of hylan G-F 20 in 4253 patients with osteoarthritis of the knee in clinical practice. Curr Med Res Opin. 2005;21:1261-1269.
17. Waddell DD. The tolerability of viscosupplementation: low incidence and clinical management of local adverse events. Curr Med Res Opin. 2003;19:575-580.
18. Waddell DD, Bricker DC. Clinical experience with the effectiveness and tolerability of hylan G-F 20 in 1047 patients with osteoarthritis of the knee. J Knee Surg. 2006;19:19-27.
19. Jackson DW, Evans NA, Thomas BM. Accuracy of needle placement into the intra-articular space of the knee. J Bone Joint Surg. 2002;84A:1522-1527.
20. Goldberg VM, Coutts RD. Pseudoseptic reactions to hylan viscosupplementation: diagnosis and treatment. Clin Orthop. 2004;419:130-137.
21. Marino AA, Waddell DD, Kolomytkin OV, et al. Assessment of immunologic mechanisms for flare reactions to Synvisc. Clin Orthop. 2006;442:187-194.
22. Leopold SS, Warme WJ, Pettis PD, et al. Increased frequency of acute local reaction to intra-articular hylan G-F 20 in patients receiving more than one course of treatment. J Bone Joint Surg. 2002;84A:1619-1223.
23. Chen AL, Desai P, Adler EM, et al. Granulomatous inflammation after hylan G-F 20 viscosupplementation of the knee: a report of six cases. J Bone Joint Surg. 2002;84A:1142-1147.
24. Dixon AS, Jacoby RK, Berry H, et al. Clinical trial of intra-articular injection of sodium hyaluronate in patients with osteoarthritis of the knee. Curr Med Res Opin. 1988;11:205-213.
25. Puhl W, Bernau A, Greiling H, et al. Intra-articular sodium hyaluronate in osteoarthritis of the knee: a multicenter, double-blind study. Osteoarthritis Cartilage. 1993;1:233-241.
26. Dougados M, Nguyen M, Listrat V, et al. High molecular weight sodium hyaluronate (hyalectin) in osteoarthritis of the knee: a 1 year placebo-controlled trial. Osteoarthritis Cartilage. 1993;1:97-103.
27. Lohmander LS, Dalen N, Englund G, et al. Intra-articular hyaluronan injections in the treatment of osteoarthritis of the knee: a randomized, double blind, placebo controlled multicentre trial. Ann Rheum Dis. 1996;55:424-431.
28. Altman RD, Moskowitz R. Intraarticular sodium hyaluronate in the treatment of patients with osteoarthritis of the knee: a randomized clinical trial. J Rheum. 1998;25:2203-2212.
29. Henderson EB, Smith EC, Pegley F, et al. Intra-articular injections of 750 kD hyaluronan in the treatment of osteoarthritis: a randomized single centre double-blind placebo-controlled trial of 91 patients demonstrating lack of efficacy. Ann Rheum Dis. 1994;53:529-534.
30. Dahlberg L, Lohmander S, Ryd L. Intraarticular injections of hyaluronan in patients with cartilage abnormalities and knee pain: a one-year double-blind, placebo-controlled study. Arthritis Rheum. 1994;37:521-528.
31. Adams ME, Atkinson MH, Lussier AJ, et al. The role of viscosupplementation with hylan G-F 20 in the treatment of osteoarthritis of the knee: a Canadian multicenter trial comparing hylan G-F 20 alone, hylan G-F 20 with non-steroial antiinflammatory drugs (NSAIDS) and NSAIDS alone. Osteoarthritis Cartilage. 1995;3:213-225.
32. Wobig M, Dickhut A, Maier R, et al. Viscosupplementation with hylan G-F 20: a 26-week controlled trial of efficacy and safety in the osteoarthritic knee. Clin Ther. 1998;20:410-423.
33. Karlsson J, Sjogren S, Lohmander LS. Comparison of two hyaluronan drugs and placebo in patients with knee osteoarthritis: a controlled, randomized, double-blind, parallel-design multicentre study. Rheum. 2002;41:1240-1248.
34. Lo GH, La Valley M, McAlindon T, et al. Intra-articular hyaluronic acid in treatment of knee osteoarthritis: a meta-analysis. JAMA. 2003;290:3115-3121.
35. Wang CT, Lin J, Chang CJ, et al. Therapeutic effects of hyaluronic acid on osteoarthritis of the knee: a meta-analysis of randomized controlled trials. J Bone Joint Surg Am. 2004;86-A:538-545.
36. Bellamy N, Campbell J, Robinson V, et al. Viscosupplementation for the treatment of osteoarthritis of the knee. Cochrane Database Syst Rev. 2006;April 19:CD005321.
37. Jones AC, Pattrick M, Doherty S, et al. Intra-articular hyaluronic acid compared to intra-articular triamcinolone hexacetonide in inflammatory knee osteoarthritis. Osteoarthritis Cartilage. 1995;3:269-273.
38. Leopold SS, Redd BB, Warme WJ, et al. Corticosteroid compared with hyaluronic acid injections for the treatment of osteoarthritis of the knee: a prospective, randomized trial. J Bone Joint Surg Am. 2003;85-A:1197-1203.
39. Caborn D, Rush J, Lanzer W, et al. A randomized, single-blind comparison of the efficacy and tolerability of hylan G-F 20 and triamcinolone hexacetonide in patients with osteoarthritis of the knee. J Rheum. 2004;31:333-343.
40. Wobig M, Bach G, Beks P, et al. The role of elastoviscosity in the efficacy of viscosupplementation for osteoarthritis of the knee: a comparison of hylan G-F 20 and a lower-molecular-weight hyaluronan. Clin Ther. 1999;21:1549-1562.
41. Jubb RW, Piva S, Beinat L, et al. A randomized, placebo (saline)-controlled clinical trial of the structure modifying effect of 500-730 KDa sodium hyaluronate (Hyalgan) in osteoarthritis of the knee. Int J Clin Pract. 2003;57:467-474.
42. Listrat V, Ayral X, Patamello F, et al. Athroscopic evaluation of potential structure modifying activity of hyaluronan in osteoarthritis of the knee. Osteoarthritis Cartilage. 1997;5:153-160.
43. Frizziero L, Govoni E, Bacchini P. Intra-articular hyaluronic acid in the treatment of osteoarthritis of the knee: clinical and morphological study. Clin Exp Rheumatol. 1998;16:441-449.
44. Pasquali Ronchetti I, Guerra D, Taparelli F, et al. Morphological analysis of knee synovial membrane biopsies from a randomized controlled clinical study comparing the effects of sodium hyaluronate and methylprednisolone acetate in osteoarthritis. Rheumatology. 2001;40:158-169.
45. Guidolin DD, Pasquali Ronchetti I, Lini E, et al. Morphological analysis of articular cartilage biopsies from a randomized, clinical study comparing the effects of 500-730 kDa sodium hyaluronate (Hyalgan) and methylprednisolone acetate on primary osteoarthritis of the knee. Osteoarthritis Cartilage. 2001;9:371-381.
46. Frizziero L, Pasquali Ronchetti I. Intra-articular treatment of osteoarthritis of the knee: an arthroscopic and clinical comparison between sodium hyaluronate and methylprednisolone acetate. J Orthop Trauma. 2002;3:89-96.
47. Conrozier T, Bertin P, Mathieu P, et al. Intra-articular injections of hylan G-F 20 in patients with symptomatic hip osteoarthritis: an open-label, multicentre, pilot study. Clin Exp Rheumatol. 2003;21:605-610.
48. Migliore A, Tormenta S, Martin LSM, et al. Open pilot study of ultrasound-guided intra-articular injection of hylan G-F 20 (Synvisc) in the treatment of symptomatic hip osteoarthritis. Clin Rheumatol. 2005;24:285-289.
49. Tikiz C, Unlu Z, Sener A, et al. Comparison of efficacy of lower and higher molecular weight viscosupplementation in the treatment of hip osteoarthritis. Clin Rheumatol. 2005;24:244-250.
50. Labbe M, Ridgeland E, Savoie FH, et al. The short-term efficacy of hyaluronic acid injections for the treatment of degenerative arthrosis of the shoulder. Arthroscopy. 2003;19:S13-S18.
51. Marshall KW. Intra-articular hyaluronan therapy. Foot Ankle Clin N Am. 2003;8:221-232.
52. Clarke S, Lock V, Duddy J, et al. Intra-articular hylan G-F 20 in the management of patellofemoral osteoarthritis of the knee. The Knee. 2005;12:57-62.